Uses of Betamex

The main active ingredient is Betamethasone in the drug, which is a synthetic corticosteroid, with a very strong glucocorticoid effect, accompanied by a negligible effect of Mineralocorticoid.
Due to little mineralocorticoid effect, active ingredient Betamethasone is very suitable in cases of pathology where water retention is detrimental. At high therapeutic doses, Betamethasone is useful in immunosuppression.

Betamex drug is used in the treatment of endocrine, musculoskeletal, collagen disorders, skin, allergies, eye, respiratory, blood, cancer and other diseases that respond to treatment with Corticosteroid drugs.
Treatment of hormonal disorders: Primary or secondary adrenocortical insufficiency (used in combination with mineralocorticoids, if possible); congenital adrenal hyperplasia; Non-purulent thyroiditis and hypercalcemia are associated with cancer. Treatment of Musculoskeletal System Disorders: The drug is used as an adjunct to short-term treatment of psoriasis-associated rheumatism; Rheumatoid arthritis can in some cases use low maintenance doses; ankylosing spondylitis; acute and subacute bursitis; nonspecific acute synovitis; leprosy; acute rheumatic fever and synovitis. Treatment of colloid-related pathologies: In the spreading period or in the maintenance treatment of some cases such as systemic lupus erythematosus, acute rheumatic myocarditis, scleroderma and dermatitis -muscle. Treatment of dermatological diseases: Pemphigus disease; herpetiform vesicular dermatitis; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative dermatitis; fungal warts; severe psoriasis; chronic dermatitis and urticaria. Treatment of allergic conditions: namely cases of seasonal or persistent allergic rhinitis, nasal polyps, bronchial asthma including asthma, contact dermatitis, atopic dermatitis also known as dermatitis neurological, drug and serum reactions. Treatment of eye diseases: Acute and chronic inflammatory and allergic processes involving the eye and its structures such as allergic conjunctivitis, allergic corneal ulceration, keratitis, herpes ocular shingles, iridocyclitis, blepharitis, chorioretinitis, choroiditis, anterior conjunctivitis spreading posteriorly, anterior segmentitis, optic neuritis, sympathetic ophthalmia; central retinitis ; posterior optic neuritis. Treatment of respiratory diseases: Treatment of symptomatic sarcoidosis; Loeffler syndrome not controlled by other methods; combination therapy with chemotherapy in the treatment of acute and disseminated pulmonary tuberculosis; pneumothorax or pulmonary fibrosis. Treatment of blood-related diseases: Spontaneous and secondary decrease in platelet count in adults; autoimmune hemolytic anemia; erythrocytopenia and anemia caused by hypoplasia or heredity; reaction to the parenteral route. Treatment of cancer pathology: Temporary treatment of leukemia and lymphoma in adults and acute blood cancer in children. Treatment of edematous states: Diuretics or proteinuria-lowering do not cause hyperuricemia in primary nephrotic syndrome or lupus erythematosus; angioedema. Other indications: Tuberculous meningitis with obstruction or risk of subarachnoid obstruction, after treatment with corresponding anti-tuberculosis chemotherapy; Ulcerative colitis or Bell's palsy.

3.1. How to use Betamex Drug Betamex is prepared in the form of hard capsules suitable for direct oral use. You should take the medicine after meals as directed by your doctor. You should not self-medicate or combine different drugs. 3.2. Therapeutic dose of the drug Treatment dose varies depending on the type of disease, severity and response of each specific person. The starting dose of Betamex may vary from 0.25 to 8mg/day, depending on the condition being treated. In mild cases, a low starting dose is usually sufficient, except in some cases where high doses are required. The initial dose should be maintained or adjusted until a therapeutic effect is achieved. Once an adequate response has been obtained, the maintenance dose should be determined by gradual dose reduction to achieve the minimum clinically effective dose. During the treatment of chronic diseases, if the disease has resolved on its own, treatment should be discontinued. The therapeutic dose may be increased in cases where people are exposed to other stresses unrelated to the disease being treated. In the case of long-term treatment, if you want to stop the drug, you must gradually reduce the dose.

Adverse effects of Betamex are similar to those of other corticosteroids, related to dose and duration of treatment.
Usually these undesirable effects are reversible or alleviated by reducing the therapeutic dose. In general, it is better to discontinue the drug in these cases.
Fluid and electrolyte disorders: Salt and water retention, congestive heart failure, potassium loss, hypertension. On the musculoskeletal system: Muscle weakness, corticosteroid-induced myopathy, decreased muscle mass, aggravation of signs and symptoms of myasthenia gravis, osteoporosis, vertebral depression, aseptic necrosis of the femoral head and head humerus, pathological long bone fracture, ligament rupture. Gastrointestinal tract: Peptic ulcer with perforation or bleeding, pancreatitis, abdominal distention or ulcerative esophagitis. Skin diseases: Slowing down the wound healing process, on young skin, thin and brittle skin; the appearance of petechiae and ecchymosis; facial erythema; increased sweating; changes in skin test results; skin allergies such as atopic dermatitis, urticaria; neurovascular edema. Nervous: Convulsions; increased intracranial pressure with papilledema causes pseudotumor in the brain often after treatment; dizziness; dizzy ; headache pain. Endocrine: Menstrual disorders; Cushing-like syndrome; reduces the growth of the embryo in the uterus; secondary adrenal and pituitary loss of response, particularly during prolonged stress. Eyes: The drug causes subcapsular cataracts, glaucoma, bulging eyes. Metabolism: Negative nitrogen balance due to protein catabolism. Psychiatric: Causes increased euphoria, lightheadedness; manifestations of severe psychological impairment; personality changes or insomnia. Other effects: Anaphylactoid reactions or hypersensitivity reactions. Usually the side effects of Betamex will go away when you stop taking the drug. You need to take the initiative to immediately notify your treating doctor or medical person if you suspect any unwanted effects of Betamex.

5.1. Contraindications of the drug Betamex Betamex drug is contraindicated for people:
Systemic fungal infections Hypersensitivity reactions to the active ingredient Betamethasone or to other corticosteroids or to any ingredient of the drug. 5.2. Precautions of Betamex Drugs People with Herpes infection, non-specific ulcerative colitis, appendicitis, recent bowel surgery; stomach ulcers; renal failure, hypertensive pathology; osteoporosis or severe myasthenia gravis. You should carefully consider and consult your treating doctor or pharmacist before using this medicine. Drugs including Betamex, even though they have been tested, still have risks when used. Nursing mothers should consult their physician after carefully weighing the benefits and risks to mother and baby. Do not arbitrarily use Betamex without carefully reading the instructions for use and instructions of the treating doctor to protect both mother and baby Above is all information about Betamex drug, patients need to read carefully the instructions. Instructions for use, consult your doctor / pharmacist before use. Absolutely do not arbitrarily buy Betamex medicine at home, because there may be unwanted side effects.